(Q39803672)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19730790%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/β-catenin antagonists against human osteosarcoma cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19730790%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19730790%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Pui Lai Rachel Ee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19730790%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Pay-Chin Leow

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19730790%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Quan Tian

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19730790%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Zheng Yang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19730790%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

1 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19730790%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19730790%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19730790%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

766-782

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19730790%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19730790%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10637-009-9311-z

6 February 2020

exact match

0 references

cites work

Frequent beta-catenin abnormalities in bone and soft-tissue tumors.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10637-009-9311-Z

Disulfiram suppresses invasive ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9 expression

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10637-009-9311-Z

A novel orthotopic murine model provides insights into cellular and molecular characteristics contributing to human osteosarcoma.

21 January 2018

1 reference

12 December 2020

Survivin as a prognostic factor for osteosarcoma patients

1 reference

12 December 2020

GSK-3-selective inhibitors derived from Tyrian purple indirubins

1 reference

12 December 2020

Natural derivatives of curcumin attenuate the Wnt/beta-catenin pathway through down-regulation of the transcriptional coactivator p300.

1 reference

12 December 2020

Identification of c-MYC as a target of the APC pathway

1 reference

12 December 2020

The inhibitory mechanism of curcumin and its derivative against beta-catenin/Tcf signaling

1 reference

12 December 2020

The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors

1 reference

12 December 2020

Survivin expression in human osteosarcoma is a marker for survival

1 reference

12 December 2020

Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols

1 reference

12 December 2020

Dominant negative LRP5 decreases tumorigenicity and metastasis of osteosarcoma in an animal model

1 reference

12 December 2020

Matrix metalloproteinases: biologic activity and clinical implications

1 reference

12 December 2020

Wnt signaling and cancer

1 reference

12 December 2020

Suppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferation

1 reference

12 December 2020

beta-Catenin/Wnt signaling regulates expression of the membrane type 3 matrix metalloproteinase in gastric cancer

1 reference

12 December 2020

Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers.

1 reference

12 December 2020

Expression of survivin and correlation with PCNA in osteosarcoma.

1 reference

12 December 2020

Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells

1 reference

12 December 2020

Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice

1 reference

12 December 2020

Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos-2 cells

1 reference

12 December 2020

C-myc and c-fos in human osteosarcoma: prognostic value of mRNA and protein expression

1 reference

12 December 2020

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells

1 reference

12 December 2020

Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC

1 reference

12 December 2020

1 reference

12 December 2020

Survivin - an anti-apoptosis protein: its biological roles and implications for cancer and beyond

1 reference

12 December 2020

Alendronate regulates cell invasion and MMP-2 secretion in human osteosarcoma cell lines.

1 reference

12 December 2020

Control of apoptosis and mitotic spindle checkpoint by survivin

1 reference

12 December 2020

Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex

1 reference

12 December 2020

Expression of LDL receptor-related protein 5 (LRP5) as a novel marker for disease progression in high-grade osteosarcoma

1 reference

12 December 2020

Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma

1 reference

12 December 2020

Matrix metalloproteinases participate in osteosarcoma invasion

1 reference

12 December 2020

Survivin dynamics increases at centromeres during G2/M phase transition and is regulated by microtubule-attachment and Aurora B kinase activity

1 reference

12 December 2020

Stage-IIB osteosarcomas around the knee. A study of MMP-9 in surviving tumour cells

1 reference

12 December 2020

Common musculoskeletal tumors of childhood and adolescence

1 reference

12 December 2020

Wnt10b induces chemotaxis of osteosarcoma and correlates with reduced survival

1 reference

12 December 2020

Apoptotic genes as potential markers of metastatic phenotype in human osteosarcoma cell lines

1 reference

12 December 2020

Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma

1 reference

12 December 2020

Inhibition of hepatocellular carcinoma invasion by suppression of claudin-10 in HLE cells.

1 reference

12 December 2020

Severe suppression of Frzb/sFRP3 transcription in osteogenic sarcoma

1 reference

12 December 2020

Promoter characterization of the novel human matrix metalloproteinase-26 gene: regulation by the T-cell factor-4 implies specific expression of the gene in cancer cells of epithelial origin

1 reference

12 December 2020

Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival

1 reference

12 December 2020

Beta-catenin regulates the gene of MMP-26, a novel metalloproteinase expressed both in carcinomas and normal epithelial cells

1 reference

12 December 2020

Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness

1 reference

12 December 2020

Beta-catenin up-regulates the expression of the urokinase plasminogen activator in human colorectal tumors

1 reference

12 December 2020

Survivin and molecular pathogenesis of colorectal cancer.

1 reference

12 December 2020

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription

1 reference

12 December 2020

Oncogene alterations in primary, recurrent, and metastatic human bone tumors

1 reference

12 December 2020

Frzb, a secreted Wnt antagonist, decreases growth and invasiveness of fibrosarcoma cells associated with inhibition of Met signaling

1 reference

12 December 2020

Regulation of microtubule stability and mitotic progression by survivin.

1 reference

12 December 2020

Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway

1 reference

12 December 2020

Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1.

1 reference

12 December 2020

Survivin expression levels as independent predictors of survival for osteosarcoma patients.

1 reference

12 December 2020

Apoptosis: a link between cancer genetics and chemotherapy

1 reference

12 December 2020